MEDX HEALTH CORP (MDX.CA) Stock Price, Forecast & Analysis
TSX-V:MDX • CA5850901037
MDX.CA Key Statistics, Chart & Performance
The current stock price of MDX.CA is 0.055 CAD. In the past month the price decreased by -15.38%. In the past year, price decreased by -21.43%.
MDX.CA Technical Analysis
ChartMill assigns a technical rating of 1 / 10 to MDX.CA. When comparing the yearly performance of all stocks, MDX.CA is a bad performer in the overall market: 86.86% of all stocks are doing better.
MDX.CA Fundamental Analysis
ChartMill assigns a fundamental rating of 1 / 10 to MDX.CA. Both the profitability and financial health of MDX.CA have multiple concerns.
MDX.CA Financial Highlights
Over the last trailing twelve months MDX.CA reported a non-GAAP Earnings per Share(EPS) of -0.02. The EPS decreased by -54.1% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -422.39% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
MDX.CA Forecast & Estimates
9 analysts have analysed MDX.CA and the average price target is 0.29 CAD. This implies a price increase of 419.27% is expected in the next year compared to the current price of 0.055.
MDX.CA Ownership
MDX.CA Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| PRN | PROFOUND MEDICAL CORP | N/A | 387.577M | ||
| TLT | THERALASE TECHNOLOGIES INC | N/A | 71.977M | ||
| CNVI | CONAVI MEDICAL CORP | N/A | 36.714M | ||
| PINK | PERIMETER MEDICAL IMAGING AI | N/A | 36.714M | ||
| NSCI | NANALYSIS SCIENTIFIC CORP | N/A | 20.768M | ||
| ASG | AURORA SPINE CORP | N/A | 20.463M | ||
| VPT | VENTRIPOINT DIAGNOSTICS LTD | N/A | 19.569M | ||
| THRM | THERMA BRIGHT INC | N/A | 3.409M | ||
| IDL | IMAGING DYNAMICS CO LTD | N/A | 929.7K |
Related stock screener links
View all stocks in the Health Care Equipment Industry | View all stocks in the Health Care Sector | View all stocks on the TSX Venture Exchange Exchange | Find stocks with similar TA and Setup ratings on the Canadian exchanges | Find stocks with similar Fundamental rating on the Canadian exchanges | Find the competitors with the best technical ratings on the Canadian exchanges | Find the competitors with the best fundamentals on the Canadian exchanges | Find the competitors with the best valuation on the Canadian exchanges | Find the competitors with the best dividend on the Canadian exchanges | Find the competitors with the best analyst ratings on the Canadian exchanges
About MDX.CA
Company Profile
MedX Health Corp. engages in the development, manufacture, and sale of medical device and software. The company is headquartered in Mississauga, Ontario. The company went IPO on 2008-02-12. The company develops and manufactures skin-related screening tools and phototherapy devices for pain relief and tissue repair. The company focuses on skin health with its SIAscopy on DermSecure telemedicine platform, utilizing its SIAscopy technology. SIAscopy is a medical device technology that is used to scan skin for suspicious moles and lesions and, including DermSecure, its telemedicine software application, and phototherapeutic medical devices, which use light energy in lower-level laser and light-emitting diode to provide treatment of pain and tissue damage in the rehabilitation market. Its products SIAMETRICS, SIMSYS, and MoleMate include hand-held devices that use patented technology utilizing light and its remittance to view up to two millimeters beneath suspicious moles and lesions in a pain free, non-invasive manner. Its SIAscopy on DermSecure telemedicine platform enables the Web-based operation of its SIAscopy scanning technology.
Company Info
MEDX HEALTH CORP
1495 Bonhill Road, Unit # 1 Mississauga
Mississauga ONTARIO L5T 1M2 CA
CEO: Scott Spearn
Employees: 15
Phone: 18883633112
MEDX HEALTH CORP / MDX.CA FAQ
What does MDX do?
MedX Health Corp. engages in the development, manufacture, and sale of medical device and software. The company is headquartered in Mississauga, Ontario. The company went IPO on 2008-02-12. The company develops and manufactures skin-related screening tools and phototherapy devices for pain relief and tissue repair. The company focuses on skin health with its SIAscopy on DermSecure telemedicine platform, utilizing its SIAscopy technology. SIAscopy is a medical device technology that is used to scan skin for suspicious moles and lesions and, including DermSecure, its telemedicine software application, and phototherapeutic medical devices, which use light energy in lower-level laser and light-emitting diode to provide treatment of pain and tissue damage in the rehabilitation market. Its products SIAMETRICS, SIMSYS, and MoleMate include hand-held devices that use patented technology utilizing light and its remittance to view up to two millimeters beneath suspicious moles and lesions in a pain free, non-invasive manner. Its SIAscopy on DermSecure telemedicine platform enables the Web-based operation of its SIAscopy scanning technology.
What is the current price of MDX stock?
The current stock price of MDX.CA is 0.055 CAD. The price decreased by -8.33% in the last trading session.
What is the dividend status of MEDX HEALTH CORP?
MDX.CA does not pay a dividend.
How is the ChartMill rating for MEDX HEALTH CORP?
MDX.CA has a ChartMill Technical rating of 1 out of 10 and a ChartMill Fundamental rating of 1 out of 10.
Where is MEDX HEALTH CORP (MDX.CA) stock traded?
MDX.CA stock is listed on the TSX Venture Exchange exchange.
Can you provide the sector and industry classification for MEDX HEALTH CORP?
MEDX HEALTH CORP (MDX.CA) operates in the Health Care sector and the Health Care Equipment & Supplies industry.
How is the valuation of MEDX HEALTH CORP (MDX.CA) based on its PE ratio?
MEDX HEALTH CORP (MDX.CA) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.02).